Patents by Inventor Jean-Jaques Bourguignon

Jean-Jaques Bourguignon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of adenine-derived compounds for the treatment of lupus
    Patent number: 8058281
    Abstract: The present invention is directed to a method of treating systemic lupus erythematosus comprising administering a compound of formula (I) wherein R1 is selected from the group consisting of CF3, a C1-C5 alkyl, and (CH2)nR4, wherein n is between 0 and 4; R2 is selected from the group consisting of (CH2)mR4 and (CH2)mAr, wherein m is between 0 and 5; R3 is selected from the group consisting of hydrogen and methyl; R4 is selected from the group consisting of phenyl, OH, a C1-C3 alkoxy, a C1-C3 dialkylamino, piperidino, and N-methylpiperazino; Ar represents ?wherein X is selected from the group consisting of F, C1, a C1-C3 alkoxy, and CF3. The compounds can be used in combination with a second compound used in the treatment of systemic lupus erythematosus.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: November 15, 2011
    Assignee: Centre National de la Recherche Scientifique (CNRS)
    Inventors: Claire Renée Jeanne Lugnier, Sylviane Paule Ghislaine Muller, Fanny Sylvie Michèle Monneaux, Jean-Jaques Bourguignon